The fight over who gets control of Revance Therapeutics and its Botox competitor, Daxxify, is coming to a close.
On Wednesday, Revance said it’s moving …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.